Does Medication-Related Osteonecrosis of the Jaw Influence the Quality of Life of Cancer Patients?

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2020 Apr 30

PMID 32344782

Citations 10

Authors

Gianluca Tenore

Ahmed Mohsen

Antonella Francesca Rossi

Gaspare Palaia

Federica Rocchetti

Andrea Cassoni

Valentino Valentini

Livia Ottolenghi

Antonella Polimeni

Umberto Romeo

Affiliations

Soon will be listed here.

Abstract

The aim of this study is to observe the influence of Medication-Related Osteonecrosis of the Jaw (MRONJ) on the physical and mental conditions of cancer patients using a Quality of Life (QoL) questionnaire during regular dental practice measures. Twenty cancer patients (8 males and 12 females) with established MRONJ were enrolled in the "MoMax" (Oral Medicine and Maxillofacial) project of the Department of Oral Sciences and Maxillofacial Surgery at "Sapienza" University of Rome, and were included in the study. The 12-item Short Form Survey was used to evaluate the QoL. Statistical analysis revealed a significant difference for Mental Component Summary (MCS) scores based on age ( = 0.018). The regression analysis revealed that the Physical Component Summary (PCS) scores were negatively influenced by the anti-resorptive medication duration ( = 0.031 and β = -1.137). No significant differences were observed with the other variables considered. The QoL of cancer patients is generally deteriorated and MRONJ may cause a further negative impact. This study highlights the possible need to include psychosocial and physical evaluations in the management process of MRONJ in cancer patients.

Citing Articles

Bone scintigraphy and positron emission tomography in the early diagnosis of MRONJ.

Pergolini D, Mohsen M, Tenore G, Palaia G, Magnifico L, Del Vecchio A Open Med (Wars). 2025; 20(1):20251143.

PMID: 39989613 PMC: 11843161. DOI: 10.1515/med-2025-1143.

Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw.

Ruan H, Chen H, Hou J, An J, Guo Y, Liu B J Bone Oncol. 2024; 49:100650.

PMID: 39651419 PMC: 11621599. DOI: 10.1016/j.jbo.2024.100650.

Education and Communication on the Topic of Osteonecrosis of the Jaw When Taking Bone-Stabilizing Drugs.

Saur F, Keinki C, Cramer A, Buentzel J, Hubner J Clin Exp Dent Res. 2024; 10(6):e70024.

PMID: 39497340 PMC: 11534630. DOI: 10.1002/cre2.70024.

Local E-rhBMP-2/β-TCP Application Rescues Osteocyte Dendritic Integrity and Reduces Microstructural Damage in Alveolar Bone Post-Extraction in MRONJ-like Mouse Model.

Dang A, Ono M, Wang Z, Tosa I, Hara E, Mikai A Int J Mol Sci. 2024; 25(12).

PMID: 38928355 PMC: 11203997. DOI: 10.3390/ijms25126648.

Peri-implantitis increases the risk of medication-related osteonecrosis of the jaws associated with osseointegrated implants in rats treated with zoledronate.

Quintao Manhanini Souza E, Toro L, Ganzaroli V, de Oliveira Alvarenga Freire J, Matsumoto M, Casatti C Sci Rep. 2024; 14(1):627.

PMID: 38182598 PMC: 10770413. DOI: 10.1038/s41598-023-49647-4.

References

De Felice F, de Vincentiis M, Valentini V, Musio D, Mezi S, Lo Mele L . Management of salivary gland malignant tumor: the Policlinico Umberto I, "Sapienza" University of Rome Head and Neck Unit clinical recommendations. Crit Rev Oncol Hematol. 2017; 120:93-97. DOI: 10.1016/j.critrevonc.2017.10.010. View

Arraras J, de la Vega F, Asin G, Rico M, Zarandona U, Eito C . The EORTC QLQ-C15-PAL questionnaire: validation study for Spanish bone metastases patients. Qual Life Res. 2013; 23(3):849-55. DOI: 10.1007/s11136-013-0511-9. View

Rosella D, Papi P, Giardino R, Cicalini E, Piccoli L, Pompa G . Medication-related osteonecrosis of the jaw: Clinical and practical guidelines. J Int Soc Prev Community Dent. 2016; 6(2):97-104. PMC: 4820581. DOI: 10.4103/2231-0762.178742. View

Freiberger J, Padilla-Burgos R, McGraw T, Suliman H, Kraft K, Stolp B . What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics. J Oral Maxillofac Surg. 2012; 70(7):1573-83. DOI: 10.1016/j.joms.2012.04.001. View

Ruggiero S, Dodson T, Fantasia J, Goodday R, Aghaloo T, Mehrotra B . American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014; 72(10):1938-56. DOI: 10.1016/j.joms.2014.04.031. View

Capocci M, Romeo U, Guerra F, Mannocci A, Tenore G, Annibali S . Medication-related osteonecrosis of the jaws (MRONJ) and quality of life evaluation: a pilot study. Clin Ter. 2017; 168(4):e253-e257. DOI: 10.7417/T.2017.2015. View

Romeo U, Galanakis A, Marias C, Del Vecchio A, Tenore G, Palaia G . Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results. Photomed Laser Surg. 2011; 29(7):447-52. DOI: 10.1089/pho.2010.2835. View

Ware Jr J, Kosinski M, Keller S . A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34(3):220-33. DOI: 10.1097/00005650-199603000-00003. View

Nortvedt M, Riise T, Myhr K, Nyland H . Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population. Med Care. 2000; 38(10):1022-8. DOI: 10.1097/00005650-200010000-00006. View

10.

Momeni A, Kim R, Kattan A, Lee G . Microsurgical head and neck reconstruction after oncologic ablation: a study analyzing health-related quality of life. Ann Plast Surg. 2013; 70(4):462-9. DOI: 10.1097/SAP.0b013e31827737a5. View

11.

Cassoni A, Romeo U, Terenzi V, Della Monaca M, Rajabtork Zadeh O, Raponi I . Adalimumab: Another Medication Related to Osteonecrosis of the Jaws?. Case Rep Dent. 2016; 2016:2856926. PMC: 4819088. DOI: 10.1155/2016/2856926. View

12.

Stanton D, Balasanian E . Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases. J Oral Maxillofac Surg. 2009; 67(5):943-50. DOI: 10.1016/j.joms.2008.12.057. View

13.

Soelver L, Oestergaard B, Rydahl-Hansen S, Wagner L . Advanced cancer patients' self-assessed physical and emotional problems on admission and discharge from hospital general wards--a questionnaire study. Eur J Cancer Care (Engl). 2012; 21(5):667-76. DOI: 10.1111/j.1365-2354.2012.01342.x. View

14.

Zhang X, Hamadeh I, Song S, Katz J, Moreb J, Langaee T . Osteonecrosis of the Jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS). J Bone Miner Res. 2015; 31(2):336-40. DOI: 10.1002/jbmr.2693. View

15.

Miksad R, Lai K, Dodson T, Woo S, Treister N, Akinyemi O . Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist. 2011; 16(1):121-32. PMC: 3228058. DOI: 10.1634/theoncologist.2010-0183. View

16.

Busija L, Pausenberger E, Haines T, Haymes S, Buchbinder R, Osborne R . Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes.... Arthritis Care Res (Hoboken). 2012; 63 Suppl 11:S383-412. DOI: 10.1002/acr.20541. View

17.

Lamb B, Brown K, Nagpal K, Vincent C, Green J, Sevdalis N . Quality of care management decisions by multidisciplinary cancer teams: a systematic review. Ann Surg Oncol. 2011; 18(8):2116-25. DOI: 10.1245/s10434-011-1675-6. View

18.

Groenvold M, Petersen M, Aaronson N, Arraras J, Blazeby J, Bottomley A . The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer. 2005; 42(1):55-64. DOI: 10.1016/j.ejca.2005.06.022. View

19.

Murphy J, Mannion C . Medication-related osteonecrosis of the jaws and quality of life: review and structured analysis. Br J Oral Maxillofac Surg. 2020; 58(6):619-624. DOI: 10.1016/j.bjoms.2020.03.010. View

20.

Hagell P, Westergren A, Arestedt K . Beware of the origin of numbers: Standard scoring of the SF-12 and SF-36 summary measures distorts measurement and score interpretations. Res Nurs Health. 2017; 40(4):378-386. DOI: 10.1002/nur.21806. View